de Paiva João Paulo Gonçalves, Roldán Daniela Giraldo, de Oliveira Vasconcelos Ricardo Anderson, Ferreira Luiz Miguel, Araújo Isaac Santos, Rangel Ana Lúcia Carrinho Ayroza, de Andrade Maíra Medeiros Pacheco, Fernandes Igor Lima, Abrahao-Machado Lucas Faria, Bishop Justin A, Jorge Jacks, Soares Ciro Dantas
Oral Diagnosis Department, Piracicaba Dental School, University of Campinas (UNICAMP), Av. Limeira, 901, Piracicaba, São Paulo, 13414-903, Brazil.
School of Dentistry, State University of Western Paraná, Cascavel, Paraná, Brazil.
Head Neck Pathol. 2025 Jul 29;19(1):94. doi: 10.1007/s12105-025-01830-x.
This study aimed to perform a systematic review of the clinicopathological, prognostic features, and HPV genotyping patterns of HPV-related multiphenotypic sinonasal carcinoma (HMSC).
This study adhered to the PRISMA 2020 guidelines and was registered in the PROSPERO database. We included case reports, case series studies, and cohort studies of HMSC indexed in the PubMed, Web of Science, Scopus, Embase, and LILACS databases published between 2017 and 2025. Collected variables were analyzed descriptively, followed by association analyses using Fisher's and Chi-squared tests, and the Kaplan-Meier method. The quality assessment of the included studies was conducted using the Joanna Briggs Institute tools.
This systematic review identified 32 studies encompassing 101 HMSC cases. The majority occurred in the nasal cavity of patients in the sixth decade of life, without significant sex predilection. Microscopically, the HMSC predominantly displayed basaloid morphology with solid and cribriform growth patterns, high mitotic activity, pleomorphism, and necrosis. Most patients underwent surgical excision and experienced no recurrence or metastasis, indicating favorable outcomes. However, treatment modality, recurrence, and distant metastasis negatively affected survival rates. HMSC cases showed strong p16 expression, variable squamous/epithelial and myoepithelial marker expression, and a high Ki67 index. HPV 33 was the most prevalent type identified.
HMSC is a heterogeneous malignant lesion with excellent overall prognosis. Detection of transcriptionally active HPV through in situ hybridization or reverse transcriptase polymerase chain reaction is critical for definitive diagnosis of HMSC.
本研究旨在对人乳头瘤病毒相关的多表型鼻窦癌(HMSC)的临床病理、预后特征及人乳头瘤病毒基因分型模式进行系统评价。
本研究遵循PRISMA 2020指南,并在PROSPERO数据库中注册。我们纳入了2017年至2025年间发表在PubMed、Web of Science、Scopus、Embase和LILACS数据库中索引的HMSC的病例报告、病例系列研究和队列研究。对收集到的变量进行描述性分析,随后使用Fisher检验和卡方检验以及Kaplan-Meier方法进行关联分析。使用乔安娜·布里格斯研究所工具对纳入研究进行质量评估。
本系统评价确定了32项研究,涵盖101例HMSC病例。大多数病例发生在60岁患者的鼻腔,无明显性别倾向。显微镜下,HMSC主要表现为基底样形态,呈实性和筛状生长模式,有高有丝分裂活性、多形性和坏死。大多数患者接受了手术切除,且无复发或转移,提示预后良好。然而,治疗方式、复发和远处转移对生存率有负面影响。HMSC病例显示p16强表达、鳞状/上皮和肌上皮标志物表达可变以及Ki67指数高。人乳头瘤病毒33是最常见的类型。
HMSC是一种异质性恶性病变,总体预后良好。通过原位杂交或逆转录聚合酶链反应检测转录活性人乳头瘤病毒对于HMSC的明确诊断至关重要。